These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9427893)
1. Outcome of chickenpox in 66 pediatric renal transplant recipients. Kashtan CE; Cook M; Chavers BM; Mauer SM; Nevins TE J Pediatr; 1997 Dec; 131(6):874-7. PubMed ID: 9427893 [TBL] [Abstract][Full Text] [Related]
2. Maintenance immunosuppression therapy and outcome of renal transplantation in North American children--a report of the North American Pediatric Renal Transplant Cooperative Study. Tejani A; Stablein D; Fine R; Alexander S Pediatr Nephrol; 1993 Apr; 7(2):132-7. PubMed ID: 8476703 [TBL] [Abstract][Full Text] [Related]
3. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Boudreaux JP; McHugh L; Canafax DM; Ascher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061 [TBL] [Abstract][Full Text] [Related]
4. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743 [TBL] [Abstract][Full Text] [Related]
6. Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine. Machado PG; Felipe CR; Park SI; Garcia R; Moreira S; Casarini D; Franco M; Alfieri F; Tedesco-Silva H; Medina-Pestana JO Braz J Med Biol Res; 2004 Sep; 37(9):1303-12. PubMed ID: 15334195 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
8. The utility of cyclosporine weaning in renal transplantation. Loertscher R; Blier L; Steinmetz O; Nohr C Ann Surg; 1992 Apr; 215(4):368-76. PubMed ID: 1558418 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous quadruple immunosuppression with cyclosporine induction therapy in high risk renal transplant recipients. Indudhara R; Khauli RB; Menon M; Stoff JS J Urol; 1994 Aug; 152(2 Pt 1):307-11. PubMed ID: 8015058 [TBL] [Abstract][Full Text] [Related]
10. Benefits of quadruple immunosuppressive therapy in recipients of living related donor kidneys. A review of 855 operations. Diethelm AG; Laskow DA; Hudson SL; Deierhoi MH; Barber WH; Barger BO; Julian BA; Gaston RS; Curtis JJ Ann Surg; 1992 Jun; 215(6):606-16; discussion 616-7. PubMed ID: 1632682 [TBL] [Abstract][Full Text] [Related]
11. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients. Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417 [TBL] [Abstract][Full Text] [Related]
12. Safe conversion from cyclosporine to azathioprine with improved renal function in pediatric renal transplantation. Kaiser BA; Lawless ST; Palmer JM; Dunn SP; Polinsky MS; Baluarte HJ Pediatr Nephrol; 1989 Oct; 3(4):401-5. PubMed ID: 2642107 [TBL] [Abstract][Full Text] [Related]
13. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants. Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332 [TBL] [Abstract][Full Text] [Related]
15. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine and cyclosporine using intensive monitoring and decreased immunosuppression. Gómez E; de Oña M; Mélon S; Alvarez R; Laures A; Rodríguez M; Pobes A; Alvarez-Grande J Nephron; 1999; 82(3):238-45. PubMed ID: 10395996 [TBL] [Abstract][Full Text] [Related]
16. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine. Sumpio BE; Dwyer JM; Flye MW Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801 [TBL] [Abstract][Full Text] [Related]
18. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases]. Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792 [TBL] [Abstract][Full Text] [Related]
19. Monotherapy with cyclosporine for chronic immunosuppression in pediatric liver transplant recipients. Dunn SP; Falkenstein K; Lawrence JP; Meyers R; Vinocur CD; Billmire DF; Weintraub WH Transplantation; 1994 Feb; 57(4):544-7. PubMed ID: 8116039 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Kahan BD Lancet; 2000 Jul; 356(9225):194-202. PubMed ID: 10963197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]